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A proteomic analysis was undertaken to identify cell wall-associated proteins of Streptococcus pyogenes.
Seventy-four distinct cell wall-associated proteins were identified, 66 of which were novel. Thirty-three proteins
were immunoreactive with pooled S. pyogenes-reactive human antisera. Biotinylation of the GAS cell surface
identified 23 cell wall-associated proteins that are surface exposed.
The gram-positive human pathogen Streptococcus pyogenes
(group A streptococcus; GAS) is the etiologic agent of numer-
ous suppurative diseases, ranging from mild skin infections,
such as pharyngitis, scarlet fever, impetigo, and cellulitis, to
severe invasive diseases such as septicemia, streptococcal toxic
shock syndrome, and necrotizing fasciitis (8). S. pyogenes ex-
presses a range of multifunctional surface proteins which fa-
cilitate adherence to and invasion of host cells, resistance to
phagocytosis, and degradation of host proteins (8). Although
many surface-exposed and secreted proteins in GAS have been
identified and characterized, there has been no systematic
analysis to identify the major cell wall-associated proteins.
To identify the major cell wall-associated proteins of GAS, a
two-dimensional (2D) sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (PAGE) proteomic analysis (6) of mutano-
lysin cell wall extracts (19) was undertaken for GAS strain
NS931 (necrotizing fasciitis isolate; serotype M69) (11), NS13
(bacteremia isolate; serotype M53) (11), and S43 (broncho-
pneumonia isolate; serotype M6) (21). Proteins of interest
were excised from 2D Coomassie blue-stained PAGE gels,
digested with trypsin, and analyzed by matrix-assisted laser
desorption ionization–time of flight (MALDI-TOF) mass spec-
trometry (MS) as described by Cordwell et al. (6). Peptide
masses were matched by searching the Swiss-Prot and
TrEMBL databases at PeptIdent (http://us.expasy.org/tools/
peptident.html). Representative 2D PAGE gels from two in-
dependent mutanolysin cell wall extractions are shown in Fig.
1A to C. The protein profiles are similar across all strains, with
molecular masses ranging from 14.4 to 77.5 kDa and a pI range
of 4.4 to 7.9. A total of 155 protein spots (51 for NS931 [Fig.
1A], 33 for NS13 [Fig. 1B], and 71 for S43 [Fig. 1C]), corre-
sponding to 74 unique proteins, were positively identified by
MALDI-TOF MS (Table 1). Several proteins were detected as
multiple isoforms in one or more strains. These results suggest
that some proteins exist in different charge states or may have
undergone posttranslational modifications. It remains to be
determined whether or not these modifications are physiolog-
ical or an artifact caused by urea carbamylation, deamidation,
or immobilized pH gradient strip overload. With the exception
of glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
(30), enolase (31), manganese-dependent superoxide dis-
mutase (26), collagen-like protein B (38), SpeM (36), FcrA
(16), M protein (13), and cysteine protease SpeB precursor
(18), all of the proteins identified in this study have not, to our
knowledge, previously been reported as cell wall associated in
S. pyogenes. Thirty-five of the 74 cell wall-associated proteins
have been previously identified in the cellular or extracellular
GAS proteomes (2, 4, 22, 27, 37) (Table 2).
Western blot analysis (3) was used to ascertain the immu-
noreactivities of proteins in cell wall extracts harvested from S.
pyogenes NS931, NS13, and S43. Immunoreactive proteins
were detected by probing the membranes with pooled human
sera obtained from the Menzies School of Health Research,
Darwin, Northern Territory, Australia. Serum samples were
pooled from 10 school-aged children residing in a remote com-
munity in northern Australia, where GAS infections are en-
demic and up to 70% of children have GAS-associated impe-
tigo (9). To act as a negative control, 2D mutanolysin extract
blots for each strain were probed with goat anti-human immu-
noglobulin G (IgG) horseradish peroxidase (HRP) only prior
to development with diaminobenzidine. The extracts were sep-
arated in two dimensions over a linear pH range of 4 to 7,
transferred to a polyvinylidene difluoride (PVDF) membrane,
and probed with the pooled human sera (Fig. 1D to F). Reac-
tive protein spots were identified according to their relative
positions (pI and molecular weight) (Fig. 1A to C). Of the 74
cell wall-associated proteins identified in this study, only 33
(45%) were identified as immunoreactive (Table 1) and there-
fore are presumably expressed during the course of human
infection. Multiple immunoreactive proteins situated near the
pH 7 end of the NS13 2D immunoblot (Fig. 1E) could not be
identified because the protein concentrations in the corre-
sponding region of the Coomassie blue-stained gel (Fig. 1B)
were below the detection threshold. Interestingly, several pro-
teins were identified as immunoreactive in only one or two of
* Corresponding author. Mailing address: School of Biological Sci-
ences, University of Wollongong, Wollongong, NSW 2522, Australia.
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FIG. 1. Two-dimensional gel electrophoresis profiles of GAS mutanolysin cell wall extracts. The extracts were harvested from GAS strains
NS931 (A, D, and G), NS13 (B, E, and H), and S43 (C, F, and I) after growth to late stationary phase (37°C for 16 h) in Todd-Hewitt medium
(Difco) supplemented with 1% (wt/vol) yeast extract without shaking. The protein extracts (170 g) were isoelectric focused over a linear pH
gradient of 4 to 7 and resolved with a 12.5% SDS-PAGE gel. (A-C) The gels were stained with colloidal Coomassie blue and destained in 1%
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anti-human IgG–HRP conjugate (Bio-Rad). Negative-control blots probed only with goat anti-human IgG–HRP conjugate contained no immu-
noreactive proteins (result not shown). (G-I) The cell surface of each strain was labeled with biotin before the mutanolysin extract was harvested.
The proteins were transferred to a PVDF membrane and probed with an SA-HRP conjugate prior to development with diaminobenzidine.
Negative-control blots of nonbiotinylated extracts contained no labeled proteins (result not shown). Protein spots identified by peptide mass
(vol/vol) acetic acid. (D-F) The proteins were transferred to a PVDF membrane and probed with a 1:100 dilution of pooled human sera from an
area of endemicity. Bound antibodies were detected using a goat fingerprinting are denoted by numbered arrows, which correspond to the proteins
in Table 1. Molecular mass markers are given in kilodaltons.
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FIG. 1—Continued.
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TABLE 1. Major cell wall-associated proteins identified in the mutanolysin extracts of GAS strains NS931, NS13, and S43 by MALDI-TOF
peptide mass fingerprinting analysisa
Function or
pathway Spot Protein
Accession
no.b
Molecular
mass
(kDa)c
pIc Peptidematchd
Coverage
(%)e
Mutanolysin
extract Immunoreactive Biotinylated
NS931 NS13 S43 NS931 NS13 S43 NS931 NS13 S43
Glycolysis 4 Putative pyruvate kinase Q8K7A3 54.5 4.96 30 59.8        
5 Putative NADP-
dependent
glyceraldehyde-3-
phosphate
dehydrogenase
Q8K707 49.5 4.96 19 56.1       
11 Phosphoglycerate kinase Q8K5W7 42.0 4.86 23 70.0       
17 6-Phosphofructokinase Q8P0S6 35.8 5.34 22 50.7     
21 Fructose-bisphosphate
aldolase
P82486 31.1 4.87 13 50.3       
27 Triosephosphate
isomerase
P82478 26.5 4.57 11 63.3        
28 2,3-Bisphosphoglycerate-
dependent
phosphoglycerate
mutase
Q8P0C1 26.0 5.10 19 77.1     
69 L-Lactate dehydrogenase Q99ZN5 35.1 5.14 9 30.7 
Carbohydrate
metabolism
1 Putative transketolase Q8K670 77.5 4.98 21 42.1         
32 Putative dTDP-4-keto-6-
deoxyglucose-3,5-
epimerase
Q9A046 22.4 5.07 10 42.1   
41 Putative
lactoylglutathione lyase
Q9A121 14.4 5.09 4 30.4 
52 Putative
phosphoglucomutase
Q99ZH8 63.3 4.78 10 25.7 
54 Putative phospho-sugar
mutase
Q878L0 48.4 4.57 8 17.7 
60 Putative dTDP-glucose-
4,6-dehydratase
Q8P199 38.8 5.41 4 12.4  
61 Glycerol-3-phosphate
dehydrogenase
[NAD(P)]
P58143 36.7 5.65 12 45.9 
67 Tagatose 1,6-diphosphate
aldolase 2
Q8K5U9 36.5 4.93 15 50.5 
Arginine
degradation
12 Ornithine
carbamoyltransferase,
catabolic
Q8P052 37.8 5.19 19 62.8        
40f Putative carbamate kinase Q8K6Q9 33.2 4.71 12 44.3      
Amino acid
biosynthesis
14 Putative branched-chain-
amino-acid
aminotransferase
Q8K7U5 37.2 4.90 6 21.4  
72 Putative glutamine
synthetase
Q8NZG4 50.5 5.21 8 19.6  
Fatty acid and
phospholipid
biosynthesis
47 Putative malonyl
coenzyme A-acyl
carrier protein
transacylase
Q879J3 34.5 6.02 5 19.1  
Pantothenate
(vitamin B5)
biosynthesis
19 Putative 2-
dehydropantoate 2-
reductase
(ketopantoate
reductase)
Q8P1F1 33.8 4.93 6 24.8   
Pyridoxine
(vitamin B6)
biosynthesis
36 Putative pyridoxamine-
phosphate oxidase
Q8K7X7 14.9 5.87 10 68.4 
Continued on following page
VOL. 73, 2005 NOTES 3141
 o
n
 N
ovem
ber 10, 2013 by guest
http://iai.asm
.org/
D
ow
nloaded from
 
TABLE 1—Continued
Function or
pathway Spot Protein
Accession
no.b
Molecular
mass
(kDa)c
pIc Peptidematchd
Coverage
(%)e
Mutanolysin
extract Immunoreactive Biotinylated
NS931 NS13 S43 NS931 NS13 S43 NS931 NS13 S43
Nucleoside
metabolism
26 Putative purine nucleoside
phosphorylase
Q878J4 28.5 4.98 12 44.4      
34 Uracil
phosphoribosyltrans-
ferase (UMP
pyrophosphorylase)
Q9A194 22.8 6.30 13 57.4  
55 GMP synthase (gluta-
mine hydrolyzing)
Q8K7E6 57.5 4.91 7 14.8 
63 Adenylosuccinate
synthetase
Q8P2U1 47.4 5.29 10 30.7 
Metabolic
enzyme
16 Putative
phosphotransacetylase
Q878S0 35.9 5.08 13 43.8    
66 Putative acetoin reduc-
tase
Q8P1U1 26.8 4.79 9 44.5 
68 Probable manganese-
dependent inorganic
pyrophosphatase
Q9A1A2 33.6 4.47 7 23.8 
Virulence
factor
8 Enolase (2-
phosphoglycerate
dehydratase)
P82479 47.2 4.74 28 65.4         
9 Arginine deiminasei Q8K5F0 46.1 4.99 31 70.5        
13 GAPDH P50467 35.8 5.34 18 61.8        
18f Cysteine protease SpeB
precursor
Q93LQ2 37.3 7.21 7 22.4  
23 Putative C3-degrading
proteinase
Q99Y63 28.6 4.89 10 43.2 
31 Superoxide dismutase
(Mn)
Q8P0D4 22.5 4.87 13 81.5     
43f Pyrogenic exotoxin M
(SpeM) (fragment)
Q7WYA3 24.1 7.87 6 25.0 
48f,g FcrA protein precursor Q54859 45.4 6.47 6 15.4  
50f,g M protein Q54840 61.7 6.24 4 6.5  
73 M protein (fragment) Q93LJ0 27.2 5.22 6 25.0 
74 M protein (fragment) O86065 21.0 5.41 5 21.7 
Protein
biosynthesis
7 Elongation factor Tu Q8K872 43.8 4.91 24 58.3     
29 Peptide deformylase Q8NZB7 22.9 5.51 11 72.5  
33 Ribosome recycling
factor
Q8P274 20.5 5.68 11 64.3    
38 Elongation factor G P82477 76.4 4.83 13 22.9  
44 Elongation factor Ts Q8K5L1 37.3 4.86 13 45.7    
57 Probable sigma54
modulation protein
(fragments)
P82482 18.4 4.45 4 30.6 
62 Seryl-tRNA synthetase Q8K635 48.1 5.17 13 38.8 
64 Elongation factor P P82459 20.5 4.85 4 29.2 
Protein
transport
22f Putative ABC trans-
porter, substrate-
binding protein
Q8P2K8 30.6 7.69 7 28.6  
39 Trigger factor Q879L7 47.1 4.39 11 27.6   
53 Putative ABC trans-
porter, ATP-binding
protein
Q99XH2 60.7 4.77 9 21.2  
65 Putative copper
homeostasis protein
(hypothetical protein)
Q8K8H0 22.6 4.79 4 24.4 
Proteolysis and
peptidolysis
6 Putative dipeptidase Q8K7L6 51.4 4.81 12 33.0        
10 Putative X-His dipeptidase Q99YT8 49.1 4.74 21 46.5 
30 Pyrrolidone-carboxylate
peptidase
Q8K8C4 23.2 5.64 7 38.6  
Continued on facing page
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the GAS strains examined (Table 1). Given the use of pooled
sera and the highly conserved nature of these proteins, an
immunoreactive protein should presumably be detected in all
three strains. However, strain-specific differences affecting pro-
tein expression levels, antigenic variation, or the sensitivity of
spot detection may account for this discrepancy.
In an attempt to determine which cell wall-associated pro-
teins are surface exposed, the cell surfaces of GAS strains
NS931, NS13, and S43 were biotinylated (1) prior to mutano-
lysin extraction and subsequent 2D Western blot analysis. Bi-
otin-labeled cell surface proteins were detected using a strepta-
vidin-HRP (SA-HRP) conjugate (Sigma). Two-dimensional
blots containing nonbiotinylated mutanolysin extract were
used as negative controls for all strains (result not shown).
Biotinylated spots were identified by MALDI-TOF MS from
the corresponding Coomassie blue-stained biotinylated cell
wall extract 2D gel. Only 23 (31%) of the identified cell wall
extract proteins were biotinylated and therefore surface ex-
posed in at least one strain (Fig. 1G to I) (Table 1).
Gram-positive proteins destined for transport across the cy-
toplasmic membrane frequently contain a hydrophobic N-ter-
minal signal sequence and a conserved C-terminal membrane
anchor motif of Leu-Pro-X-Thr-Gly (LPXTG) (5). Following
protein translocation across the cytoplasmic membrane, the
TABLE 1—Continued
Function or
pathway Spot Protein
Accession
no.b
Molecular
mass
(kDa)c
pIc Peptidematchd
Coverage
(%)e
Mutanolysin
extract Immunoreactive Biotinylated
NS931 NS13 S43 NS931 NS13 S43 NS931 NS13 S43
45 Putative methionine
aminopeptidase
Q8K718 31.6 4.84 5 31.5 
Chaperone 2 Chaperone protein DnaK P95831 64.8 4.62 24 47.6        
3 60-kDa chaperonin
GroEL
Q8K5M5 56.9 4.75 35 69.6       
Stress protein 35 Putative alkyl
hydroperoxidase
Q99XR7 20.5 4.65 9 58.6     
49 Putative glutathione
reductase
Q8P1H3 48.9 5.66 5 11.1  
Transcription
factor
58 Transcription elongation
factor GreA
Q9A1C4 17.7 4.67 7 61.3 
Adhesin 59f,g Collagen-like protein B
(fragment)
Q9AGC4 46.7 4.60 4 10.8 
Housekeeping 15 Putative alcohol
dehydrogenase I
Q9A1X7 35.4 4.89 6 20.7 
24 Putative phosphoprotein
phosphatase
Q99YM9 27.0 4.60 19 80.9  
25 Adenylate kinase Q8K8X1 23.7 4.83 13 79.7  
Unknown
function
20 Hypothetical UPF0082
protein SPy0316/
SpyM3_0231/SPs16 28/
spyM18_0311
Q9A1E6 25.9 4.49 6 29.0 
37 Hypothetical phage
protein spyM18_0356
Q8P2H6 25.1 5.37 4 13.6 
42 Hypothetical phage
protein spyM18_1764
Q8NZS3 22.7 4.63 3 20.2 
46 Hypothetical protein
SPy1262
Q99ZE5 19.9 4.93 9 42.5   
51 Hypothetical protein
SpyM3_0548
Q8K7Z2 15.4 6.05 4 21.2 
56 Conserved hypothetical
protein SPs1095
Q878P1 17.5 4.65 6 54.6 
70 Conserved protein
SpyM18_1567
Q8P050 26.6 4.67 5 28.6 
71 Hypothetical protein
(phage associated)
SPs0647
Q879B2 26.8 5.10 5 21.0 
a Identified proteins are indicated by a plus sign.
b Swiss-Prot or TrEMBL accession number.
c Theoretical values obtained from Swiss-Prot or TrEMBL database.
d Number of tryptic peptides detected by MALDI-TOF MS that could be matched to the protein.
e Percentage of the protein sequence covered by the matched peptides.
f Contains a putative secretion signal sequence identified by SignalP3.0 signal peptide prediction server (http://www.cbs.dtu.dk/services/SignalP/).
g Contains a C-terminal LPXTG membrane anchor motif identified by Pfam motif search (http://pfam.wustl.edu/hmmsearch.shtml).
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signal peptide is proteolytically removed by signal peptidase.
Proteolytic cleavage of the LPXTG motif by sortase facilitates
the covalent cross-linking of the protein to the cell wall (28). In
this study, many GAS cell wall-associated proteins lack appar-
ent secretion signal sequences and the LPXTG membrane
anchor sequence (Table 1). Similarly, a number of secreted
GAS proteins lack secretion signals (2, 22, 27). The absence of
a signal peptide and LPXTG motif suggests that these proteins
are either passively released during autolysis or that an alter-
native secretory pathway may exist for many secreted GAS
proteins. Although the mechanism by which these proteins are
transported to the cell surface is unknown, internal signal se-
quences, posttranslational acylation, or an association with a
secreted protein may be involved (31). Recently, asymmetric
protein secretion of GAS SpeB was shown to occur at distinct
cytoplasmic membrane microdomains termed ExPortals (35).
The role that this structure plays in the secretion of other GAS
proteins is currently unknown. We also note the possibility that
cytosolic proteins passively released by autolysis may have ad-
sorbed to the GAS cell surface.
SpeB is an extracellular and surface-associated cysteine pro-
tease virulence factor produced by most GAS strains (18) that
can efficiently degrade the majority of proteins in the secreted
GAS proteome (2). Twenty-five of the cell wall-associated pro-
teins described in this communication have previously been
identified in the extracellular proteomes of GAS SpeB mutants
(2, 4, 22). The identification of these proteins in the cell walls
of SpeB-positive strains suggests that while these proteins are
associated with the GAS cell wall during late stationary phase,
they are efficiently protected from SpeB-mediated degrada-
TABLE 2. Cell-wall associated proteins previously characterized as cellular or secreted in GAS
Functional category Protein
Positivity for indicated characteristic
Cellulara Secretedb Cell wallc
Chaperonin DnaK   
GroEL   
Plasminogen
binding
Enolase   
Glyceraldehyde-3-phosphate dehydrogenase   
Glycolytic pathway 6-Phosphofructokinase   
Phosphoglycerate kinase   
Fructose-bisphosphate aldolase   
Triosephosphate isomerase   
Phosphoglycerate mutase   
Pyruvate kinase   
Virulence factor M protein   
SpeB  
Protein synthesis Ribosome recycling factor   
Elongation factor Tu   
Elongation factor Ts   
Elongation factor G   
Elongation factor P  
Peptide deformylase  
Urea cycle pathway Arginine deaminase  
Ornithine carbamoyltransferase  
Carbamate kinase  
Cell wall synthesis dTDP-4-keto-6-deoxyglucose-3,5-epimerase  
Stress protein Alkyl hydroperoxidase  
Superoxide dismutase (Mn)  
Nucleotide synthesis GMP synthase  
Housekeeping L-Lactate dehydrogenase   
NADP-dependent glyceraldehyde-3-phosphate dehydrogenase   
2-Dehydropantoate 2-reductase   
Transketolase   
Manganese-dependent inorganic pyrophosphatase   
Dipeptidase  
Adenylate kinase  
ABC transporter (ATP-binding protein)  
Branched-chain-amino-acid aminotransferase  
Phosphotransacetylase  
a Data obtained from the work of Thongboonkerd et al. (37).
b Data obtained from the work of Aziz et al. (2), Chaussee et al. (4), Lei et al. (22), Nakamura et al. (27), and Thongboonkerd et al. (37).
c This study.
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tion. Future studies may be performed with biochemically or
genetically inactivated SpeB to test this hypothesis.
A significant number of traditional cytoplasmic proteins
were also identified as cell wall-associated immunogens in this
work. Several cytosolic proteins, such as the glycolysis pathway
enzymes, have been reported as cell wall associated in GAS or
other prokaryotic species. The glycolytic enzyme GAPDH, also
referred to as the plasmin receptor protein (Plr), is a well-
characterized GAS cell surface protein with plasminogen bind-
ing (40) and ADP-ribosylating (29) activities. This multifunc-
tional protein binds fibronectin, lysozyme, myosin, and actin
(30) and elicits signal transduction events in human pharyngeal
cells (32). Streptococcal enolase is a glycolytic and major plas-
minogen-binding protein located on the cell surfaces of most
GAS strains (12). Streptococcal enolase has been implicated in
GAS adherence to and invasion of human pharyngeal cells
(33) and is a highly immunogenic autoantigen with a possible
role in the initiation of poststreptococcal sequelae (15). Phos-
phoglycerate kinase is a glycolytic and major outer surface
protein of Streptococcus oralis (39) and Streptococcus agalactiae
(group B streptococcus) (17).
Consistent with our findings, the normally cytoplasmic chap-
eronins DnaK and GroEL have been identified as immunore-
active antigens of S. pyogenes (23, 24). Although these chap-
erones have not previously been characterized as GAS cell wall
constituents, homologs of DnaK and GroEL are located in the
cell walls of S. agalactiae (17). Elongation factor Tu is localized
in the cell walls of S. oralis (39). Other factors involved in
protein synthesis, such as ribosome recycling factor and protein
translation elongation factors G, Ts, and P, are expressed on
the cell surface of S. oralis (39).
The three components of the arginine deiminase pathway,
which consists of ornithine carbamoyltransferase, arginine de-
iminase, and carbamate kinase, were identified as cell wall
associated in this study. The enzymes of this system catalyze
the breakdown of arginine to ornithine, CO2, and two mole-
cules of ammonia, with the concomitant production of ATP
(7). Ornithine carbamoyltransferase is a bona fide cell wall
protein of S. agalactiae (17), Streptococcus sanguis (14), and
Streptococcus suis (41). GAS arginine deiminase, also known as
the streptococcal acid glycoprotein, is thought to play a role in
virulence factor expression and GAS internalization into epi-
thelial cells (10, 25).
Although an association between biotinylated proteins and
immunoreactivity was established, some biotinylated cell sur-
face proteins were not immunoreactive. To account for this, we
suggest that these proteins either are poor immunogens or are
expressed at low levels during GAS infection. Conversely,
some immunoreactive proteins were not found to be biotinyl-
ated, which may indicate the absence of surface-exposed lysine
residues for biotinylation. Alternatively, proteins with only a
small number of surface-exposed lysine residues may have
been below the limit of detection used in this study. For ex-
ample, the M protein of NS13 exhibited immunoreactivity
against the human antiserum (Fig. 1E, spot 50) but was not
found to be biotinylated. Cleavage of surface-exposed M pro-
tein by SpeB (20, 34) may explain the apparent lack of M
protein biotinylation in this study. Lack of M protein immune
reactivity in GAS strains NS931 and S43 may suggest that the
individuals from an area of endemicity from whom the serum
was derived had not been exposed to these GAS M types. M
protein fragments were detected in each of these strains (Fig.
1A and C; spots 73 and 74).
Numerous surface-exposed cell wall proteins have been
identified as vaccine candidates in GAS (8). However, a safe
and efficacious commercial GAS vaccine has yet to be devel-
oped. In this study, we have undertaken a systematic proteomic
analysis to extend the range of proteins known to associate
with the GAS cell wall. In summary, a total of 74 distinct
proteins were identified in the cell wall extracts of three GAS
strains. Thirty-three of these proteins were immunoreactive
against pooled human sera, and 23 were identified as surface
exposed. Further characterization of these proteins is required
to elucidate their precise role in GAS pathogenesis. Taken
together, these data illustrate the usefulness of proteomics in
analyzing the cell surface topology of GAS.
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